Omeros reported $8.96M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acelrx Pharmaceuticals ACRX:US $ 21.82M 9.16M
Adma Biologics ADMA:US $ 69.5M 18.42M
Aerie Pharmaceuticals AERI:US $ 56.44M 19.25M
Alnylam Pharmaceuticals ALNY:US $ 534.08M 285.89M
Biomarin Pharmaceutical BMRN:US $ 605.44M 18.16M
Cytokinetics CYTK:US $ 115.42M 2.76M
Dynavax Technologies DVAX:US $ 179.42M 256.77M
Gilead Sciences GILD:US $ 4296M 1042M
Heron Therapeutics HRTX:US $ 56.91M 33.63M
Insmed INSM:US $ 515.7M 201.08M
Intercept Pharmaceuticals ICPT:US $ 48.32M 36.39M
Knight Therapeutics Inc GUD:CN C$ 4.61M 4.42M
Macrogenics MGNX:US $ 47.33M 76.14M
Mirati Therapeutics MRTX:US $ 293.42M 100.32M
Omeros OMER:US $ 8.96M 91.84M
Pacira Pharmaceuticals PCRX:US $ 226.75M 358.83M
Pfizer PFE:US $ 2470M 526M
Regulus Therapeutics RGLS:US $ 53.9M 6.48M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M
Sarepta Therapeutics SRPT:US $ 1233.88M 881.99M
United Therapeutics UTHR:US $ 813.3M 81.5M
Vertex Pharmaceuticals VRTX:US $ 7600.1M 805.1M
Vital Therapies VTL:US $ 95.71M 8.85M